288 related articles for article (PubMed ID: 31186424)
21. Structure and activity of the RNA-targeting Type III-B CRISPR-Cas complex of Thermus thermophilus.
Staals RHJ; Agari Y; Maki-Yonekura S; Zhu Y; Taylor DW; van Duijn E; Barendregt A; Vlot M; Koehorst JJ; Sakamoto K; Masuda A; Dohmae N; Schaap PJ; Doudna JA; Heck AJR; Yonekura K; van der Oost J; Shinkai A
Mol Cell; 2013 Oct; 52(1):135-145. PubMed ID: 24119403
[TBL] [Abstract][Full Text] [Related]
22. RNA processing by the CRISPR-associated NYN ribonuclease.
Chi H; White MF
Biochem J; 2024 Jun; 481(12):793-804. PubMed ID: 38785320
[TBL] [Abstract][Full Text] [Related]
23. A scoutRNA Is Required for Some Type V CRISPR-Cas Systems.
Harrington LB; Ma E; Chen JS; Witte IP; Gertz D; Paez-Espino D; Al-Shayeb B; Kyrpides NC; Burstein D; Banfield JF; Doudna JA
Mol Cell; 2020 Aug; 79(3):416-424.e5. PubMed ID: 32645367
[TBL] [Abstract][Full Text] [Related]
24. Structural Variation of Type I-F CRISPR RNA Guided DNA Surveillance.
Pausch P; Müller-Esparza H; Gleditzsch D; Altegoer F; Randau L; Bange G
Mol Cell; 2017 Aug; 67(4):622-632.e4. PubMed ID: 28781236
[TBL] [Abstract][Full Text] [Related]
25. Approaches to study CRISPR RNA biogenesis and the key players involved.
Behler J; Hess WR
Methods; 2020 Feb; 172():12-26. PubMed ID: 31325492
[TBL] [Abstract][Full Text] [Related]
26. Sensitive analysis of single nucleotide variation by Cas13d orthologs, EsCas13d and RspCas13d.
Qiao X; Gao Y; Li J; Wang Z; Qiao H; Qi H
Biotechnol Bioeng; 2021 Aug; 118(8):3037-3045. PubMed ID: 33964175
[TBL] [Abstract][Full Text] [Related]
27. Unity among the diverse RNA-guided CRISPR-Cas interference mechanisms.
Ganguly C; Rostami S; Long K; Aribam SD; Rajan R
J Biol Chem; 2024 Jun; 300(6):107295. PubMed ID: 38641067
[TBL] [Abstract][Full Text] [Related]
28. Crystal Structures of Csm2 and Csm3 in the Type III-A CRISPR-Cas Effector Complex.
Takeshita D; Sato M; Inanaga H; Numata T
J Mol Biol; 2019 Feb; 431(4):748-763. PubMed ID: 30639408
[TBL] [Abstract][Full Text] [Related]
29. Molecular insights into DNA interference by CRISPR-associated nuclease-helicase Cas3.
Gong B; Shin M; Sun J; Jung CH; Bolt EL; van der Oost J; Kim JS
Proc Natl Acad Sci U S A; 2014 Nov; 111(46):16359-64. PubMed ID: 25368186
[TBL] [Abstract][Full Text] [Related]
30. Structure Studies of the CRISPR-Csm Complex Reveal Mechanism of Co-transcriptional Interference.
You L; Ma J; Wang J; Artamonova D; Wang M; Liu L; Xiang H; Severinov K; Zhang X; Wang Y
Cell; 2019 Jan; 176(1-2):239-253.e16. PubMed ID: 30503210
[TBL] [Abstract][Full Text] [Related]
31. Cas13b Is a Type VI-B CRISPR-Associated RNA-Guided RNase Differentially Regulated by Accessory Proteins Csx27 and Csx28.
Smargon AA; Cox DBT; Pyzocha NK; Zheng K; Slaymaker IM; Gootenberg JS; Abudayyeh OA; Essletzbichler P; Shmakov S; Makarova KS; Koonin EV; Zhang F
Mol Cell; 2017 Feb; 65(4):618-630.e7. PubMed ID: 28065598
[TBL] [Abstract][Full Text] [Related]
32. The tracrRNA and Cas9 families of type II CRISPR-Cas immunity systems.
Chylinski K; Le Rhun A; Charpentier E
RNA Biol; 2013 May; 10(5):726-37. PubMed ID: 23563642
[TBL] [Abstract][Full Text] [Related]
33. Cross-cleavage activity of Cas6b in crRNA processing of two different CRISPR-Cas systems in Methanosarcina mazei Gö1.
Nickel L; Ulbricht A; Alkhnbashi OS; Förstner KU; Cassidy L; Weidenbach K; Backofen R; Schmitz RA
RNA Biol; 2019 Apr; 16(4):492-503. PubMed ID: 30153081
[TBL] [Abstract][Full Text] [Related]
34. RNA Guide Complementarity Prevents Self-Targeting in Type VI CRISPR Systems.
Meeske AJ; Marraffini LA
Mol Cell; 2018 Sep; 71(5):791-801.e3. PubMed ID: 30122537
[TBL] [Abstract][Full Text] [Related]
35. Structure of an RNA silencing complex of the CRISPR-Cas immune system.
Spilman M; Cocozaki A; Hale C; Shao Y; Ramia N; Terns R; Terns M; Li H; Stagg S
Mol Cell; 2013 Oct; 52(1):146-52. PubMed ID: 24119404
[TBL] [Abstract][Full Text] [Related]
36. Comparative analysis ofCas6b processing and CRISPR RNA stability.
Richter H; Lange SJ; Backofen R; Randau L
RNA Biol; 2013 May; 10(5):700-7. PubMed ID: 23392318
[TBL] [Abstract][Full Text] [Related]
37. Molecular determinants for CRISPR RNA maturation in the Cas10-Csm complex and roles for non-Cas nucleases.
Walker FC; Chou-Zheng L; Dunkle JA; Hatoum-Aslan A
Nucleic Acids Res; 2017 Feb; 45(4):2112-2123. PubMed ID: 28204542
[TBL] [Abstract][Full Text] [Related]
38. Structural insights into the modulatory role of the accessory protein WYL1 in the Type VI-D CRISPR-Cas system.
Zhang H; Dong C; Li L; Wasney GA; Min J
Nucleic Acids Res; 2019 Jun; 47(10):5420-5428. PubMed ID: 30976796
[TBL] [Abstract][Full Text] [Related]
39. Cmr4 is the slicer in the RNA-targeting Cmr CRISPR complex.
Zhu X; Ye K
Nucleic Acids Res; 2015 Jan; 43(2):1257-67. PubMed ID: 25541196
[TBL] [Abstract][Full Text] [Related]
40. Two Distant Catalytic Sites Are Responsible for C2c2 RNase Activities.
Liu L; Li X; Wang J; Wang M; Chen P; Yin M; Li J; Sheng G; Wang Y
Cell; 2017 Jan; 168(1-2):121-134.e12. PubMed ID: 28086085
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
